INTERNATIONAL DESK: Biopharmaceutical major Biocon NSE -0.77 % has its eyes set on the US insulin market, which is expected…
Browsing: biocon
INTERNATIONAL DESK: Biocon Biologics, a subsidiary of the Bengaluru-based pharmaceutical firm Biocon, announced on Monday it has received an “exclusive…